SZ 343 (Ondansetron Orally Disintegrating 8 mg)

Pill imprint SZ 343 has been identified as Ondansetron hydrochloride (orally disintegrating) 8 mg.

Ondansetron is used in the treatment of nausea/vomiting; alcohol dependence; gastroenteritis; obsessive compulsive disorder; nausea/vomiting, chemotherapy induced (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 8 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for SZ 343

Ondansetron hydrochloride (orally disintegrating) 8 mg SZ 343
Ondansetron hydrochloride (orally disintegrating)
Imprint:
SZ
343
Strength:
8 mg
Color:
White
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
5HT3 receptor antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5239
Inactive Ingredients:
aspartame
calcium stearate
silicon dioxide colloidal
mannitol
microcrystalline cellulose
polacrilin potassium
sodium starch glycolate type A potato
magnesium silicate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-6124 A S Medication Solutions LLC (repackager)
21695-0479 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)